Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Feb 8;2019(2):rjz030.
doi: 10.1093/jscr/rjz030. eCollection 2019 Feb.

Glioblastoma and prolactinoma: a rare simultaneous occurrence

Affiliations
Case Reports

Glioblastoma and prolactinoma: a rare simultaneous occurrence

Abdulaziz Alshalawi et al. J Surg Case Rep. .

Abstract

The simultaneous development of two or more primary central nervous system (CNS) tumors of different cell types represents 0.9% of all diagnosed CNS tumors. To the best of our knowledge, the simultaneous occurrence of glioblastoma and pituitary adenomas has been reported four times in the English literature, with only two cases harboring prolactinoma and glioblastoma. We report a case of a 42-year-old male who was diagnosed with a sporadic co-occurrence of glioblastoma and a prolactin-secreting pituitary adenoma (prolactinoma). This case report discusses the clinical presentation, radiological/histopathological features, and outcome as well as reviewing the pertinent medical literature. Glioblastoma and a prolactin-secreting adenoma may be detected within the same patient. Further studies are required to delineate the tumorigenesis of the development and co-occurrence of multiple intracranial tumors.

PubMed Disclaimer

Figures

Figure 1:
Figure 1:
Preoperative neuroimaging of the patient—CT (a and b) and MRI ((cf )—with contrast enhancement), showing a centrally necrotic peripherally enhancing mass lesion in the left posteromedial temporal lobe representing glioblastoma. The non-enhancing component of the tumor extended to the left thalamus. Another sellar and suprasellar mass lesion representing a pituitary macroadenoma. (gi) The MR spectroscopy shows a very low N-acetylaspartate (NAA) and high choline keeping up with a malignant tumor.
Figure 2:
Figure 2:
(a) High power view showing hyperchromatic glial nuclei and a couple of mitoses (green arrows). (b) Microvascular proliferation (arrows). (c) (GFAP) immunostain cytoplasmic positivity confirms astrocytic lineage; notice the negatively staining microvascular proliferation. (d) Ki-67 labeling index is high.

References

    1. Haciyakupoglu E, Sav A, Haciyakupoglu S, Walter J. Multiple intracranial tumors: coexistence of a glioblastoma and null cell pituitary adenoma within the same patient. Clin Neurol Neurosurg 2014;120:120–3. - PubMed
    1. Naydenov E, Marinov M, Nachev S. Two different primary brain tumors, glioblastoma multiforme and pituitary adenoma, in association with colorectal carcinoma: an unusual case of nonfamilial Turcot’s syndrome? J Neurol Surg A Cent Eur Neurosurg 2012;73:410–2. - PubMed
    1. Molitch ME. Diagnosis and treatment of pituitary adenomas: a review. J Am Med Assoc 2017;317:516–524. - PubMed
    1. Hanif F, Muzaffar K, Perveen K, Malhi SM, Simjee SU. Glioblastoma multiforme: a review of its epidemiology and pathogenesis through clinical presentation and treatment. Asian Pac J Cancer Prev 2017;18:3–9. - PMC - PubMed
    1. Miyagi A, Maeda K, Sugawara T, Sawada T, Tsubokawa T. Triple primary intracranial tumors of different cell types: a case report. No shinkei geka. Neurol Surg 1995;23:531–6. - PubMed

Publication types